Exosens (EPA:EXENS)

Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of EUR 2.16 billion. The enterprise value is 2.27 billion.

Market Cap	2.16B
Enterprise Value	2.27B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	May 28, 2025

Share Statistics

Exosens has 50.77 million shares outstanding. The number of shares has increased by 37.23% in one year.

Current Share Class	50.77M
Shares Outstanding	50.77M
Shares Change (YoY)	+37.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	24.32%
Float	30.73M

Valuation Ratios

The trailing PE ratio is 69.84 and the forward PE ratio is 26.43.

PE Ratio	69.84
Forward PE	26.43
PS Ratio	5.49
PB Ratio	5.24
P/TBV Ratio	26.03
P/FCF Ratio	39.33
P/OCF Ratio	22.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.19, with an EV/FCF ratio of 41.35.

EV / Earnings	89.07
EV / Sales	5.77
EV / EBITDA	23.19
EV / EBIT	29.60
EV / FCF	41.35

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.63.

Current Ratio	2.94
Quick Ratio	2.07
Debt / Equity	0.63
Debt / EBITDA	2.66
Debt / FCF	4.75
Interest Coverage	2.15

Financial Efficiency

Return on equity (ROE) is 9.95% and return on invested capital (ROIC) is 8.03%.

Return on Equity (ROE)	9.95%
Return on Assets (ROA)	6.52%
Return on Invested Capital (ROIC)	8.03%
Return on Capital Employed (ROCE)	10.82%
Revenue Per Employee	301,281
Profits Per Employee	19,519
Employee Count	1,401
Asset Turnover	0.53
Inventory Turnover	1.92

Taxes

In the past 12 months, Exosens has paid 11.13 million in taxes.

Income Tax	11.13M
Effective Tax Rate	26.62%

Stock Price Statistics

The stock price has increased by +88.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+88.14%
50-Day Moving Average	39.45
200-Day Moving Average	27.20
Relative Strength Index (RSI)	44.18
Average Volume (20 Days)	131,450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of EUR 394.08 million and earned 25.53 million in profits. Earnings per share was 0.61.

Revenue	394.08M
Gross Profit	229.34M
Operating Income	76.81M
Pretax Income	41.81M
Net Income	25.53M
EBITDA	94.40M
EBIT	76.81M
Earnings Per Share (EPS)	0.61

Balance Sheet

The company has 150.19 million in cash and 261.28 million in debt, giving a net cash position of -111.08 million or -2.19 per share.

Cash & Cash Equivalents	150.19M
Total Debt	261.28M
Net Cash	-111.08M
Net Cash Per Share	-2.19
Equity (Book Value)	412.60M
Book Value Per Share	8.13
Working Capital	207.23M

Cash Flow

In the last 12 months, operating cash flow was 96.25 million and capital expenditures -41.26 million, giving a free cash flow of 55.00 million.

Operating Cash Flow	96.25M
Capital Expenditures	-41.26M
Free Cash Flow	55.00M
FCF Per Share	1.08

Margins

Gross margin is 58.20%, with operating and profit margins of 19.49% and 7.79%.

Gross Margin	58.20%
Operating Margin	19.49%
Pretax Margin	10.61%
Profit Margin	7.79%
EBITDA Margin	23.96%
EBIT Margin	19.49%
FCF Margin	13.96%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.24%.

Dividend Per Share	0.10
Dividend Yield	0.24%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.23%
Shareholder Yield	-36.98%
Earnings Yield	1.18%
FCF Yield	2.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exosens has an Altman Z-Score of 2.71 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	8